Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice

Frontiers in Behavioral Neuroscience

Volumn , Issue OCTOBER 2012, 2012, Pages 1-18

  Hattori, Satoko ^a,b   Takao, Keizo ^b,c,d   Tanda, Koichi ^d,e   Toyama, Keiko ^a,d   Shintani, Norihito ^f   Baba, Akemichi ^f,g   Hashimoto, Hitoshi ^f   Miyakawa, Tsuyoshi ^a,b,c,d  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Behavior; Hyperactivity; Knockout mouse; Mental disorder; Pituitary adenylate cyclase activating polypeptide; Social interaction; Working memory

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; GENE; GENE CONTROL; GENE FUNCTION; GENE INACTIVATION; GENOTYPE; HOT PLATE TEST; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE GENE; KNOCKOUT MOUSE; LATENT PERIOD; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NEUROPSYCHIATRY; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PREPULSE INHIBITION; PROTEIN FUNCTION; ROTAROD TEST; SOCIAL INTERACTION; STARTLE REFLEX; TASK PERFORMANCE; WORKING MEMORY;

EID: 84867594179     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00058     Document Type: Article

References (58)

1. Anckarsäter, H., Stahlberg, O., Larson, T., Hakansson, C., Jutblad, S. B., Niklasson, L., Nydén, A., Wentz, E., Westergren, S., Cloninger, C. R., Gillberg, C., and Rastam, M. (2006). The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am. J. Psychiatry 163, 1239-1244.
2. Arimura, A. (1998). Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 48, 301-331.
3. Castellanos, F. X., and Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3, 617-628.
4. Chen, J., Lipska, B. K., and Weinberger, D. R. (2006). Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol. Psychiatry 59, 1180-1188.
5. Crabbe, J. C., Wahlsten, D., and Dudek, B. C. (1999). Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670-1672.
6. Crawley, J. N. (1985). Exploratory behavior models of anxiety in mice. Neurosci. Biobehav. Rev. 9, 37-44.
7. Crawley, J. N. (2004). Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10, 248-258.
8. Crawley, J. N., Belknap, J. K., Collins, A., Crabbe, J. C., Frankel, W., Henderson, N., Hitzemann, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., Wehner, J. M., Wynshaw-Boris, A., and Paylor, R. (1997). Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl.) 132, 107-124.
9. Crusio, W. E. (2004). Flanking gene and genetic background problems in genetically manipulated mice. Biol. Psychiatry 56, 381-385.
10. Falluel-Morel, A., Chafai, M., Vaudry, D., Basille, M., Cazillis, M., Aubert, N., Louiset, E., de Jouffrey, S., le Bigot, J. F., Fournier, A., Gressens, P., Rostène, W., Vaudry, H., and Gonzalez, B. J. (2007). The neu-ropeptide pituitary adenylate cyclase-activating polypep-tide exerts anti-apoptotic and differentiating effects during neu-rogenesis: focus on cerebellar granule neurones and embryonic stem cells. J. Neuroendocrinol. 19, 321-327.
11. Gaszner, B., Kormos, V., Kozicz, T., Hashimoto, H., Reglodi, D., and Helyes, Z. (2012). The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus. Neuroscience 202, 283-299.
12. Gerlai, R. (1996). Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19, 177-181.
13. Goldberg, D., and Fawcett, J. (2012). The importance of anxiety in both major depression and bipolar disorder. Depress. Anxiety 29, 471-478.
14. Gray, S. L., Cummings, K. J., Jirik, F. R., and Sherwood, N. M. (2001). Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol. Endocrinol. 15, 1739-1747.
15. Hamelink, C., Tjurmina, O., Damadzic, R., Young, W. S., Weihe, E., Lee, H.-W., and Eiden, L. E. (2002). Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in cat-echolamine regulation and gluco-homeostasis. Proc. Natl. Acad. Sci. U.S.A. 99, 461-466.
16. Hammack, S. E., Cheung, J., Rhodes, K. M., Schutz, K. C., Falls, W. A., Braas, L. M., and May, V. (2009). Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neu-rotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 34, 833-843.
17. Hammack, S. E., Roman, C. W., Lezak, K. R., Kocho-Shellenberg, M., Grimming, B., Falls, W. A., Braas, L. M., and May, V. (2010). Roles for pituitary adeny-late cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress. J. Mol. Neurosci. 42, 327-340.
18. Hannibal, J., Jamen, F., Nielsen, H. S., Journot, L., Brabet, P., and Fahrenkrug, J. (2001). Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activationg polypeptide type 1 receptor. J. Neurosci. 21, 4883-4890.
19. Hashimoto, H., Hashimoto, R., Shintani, N., Tanaka, K., Yamamoto, A., Hatanaka, M., Guo, X., Morita, Y., Tanida, M., Nagai, K., Takeda, M., and Baba, A. (2009). Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J. Neurochem. 110, 595-602.
20. Hashimoto, H., Shintani, N., and Baba, A. (2006). New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann. N.Y. Acad. Sci. 1070, 75-89.
21. Hashimoto, H., Shintani, N., Tanaka, K., Mori, W., Hirose, M., Matsuda, T., Sakaue, M., Miyazaki, J., Niwa, H., Tashiro, F., Yamamoto, K., Koga, K., Tomimoto, S., Kunugi, A., Suetake, S., and Baba, A. (2001). Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl. Acad. Sci. U.S.A. 98, 13355-13360.
22. Hashimoto, R., Hashimoto, H., Shintani, N., Chiba, S., Hattori, S., Okada, T., Nakajima, M., Tanaka, K., Kawagishi, N., Nemoto, K., Mori, T., Ohnishi, T., Noguchi, H., Hori, H., Suzuki, T., Iwata, N., Ozaki, N., Nakabayashi, T., Saitoh, O., Kosuga, A., Tatsumi, M., Kamijima, K., Weinberger, D. R., Kunugi, H., and Baba, A. (2007). Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol. Psychiatry 12, 1026-1032.
23. Hashimoto, R., Hashimoto, H., Shintani, N., Ohi, K., Hori, H., Saitoh, O., Kosuga, A., Tatsumi, M., Iwata, N., Ozaki, N., Kamijima, K., Baba, A., Takeda, M., and Kunugi, H. (2010). Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Neurosci. Lett. 468, 300-302.
24. Hattori, T., Baba, K., Matsuzaki, S., Honda, A., Miyoshi, K., Inoue, K., Taniguchi, M., Hashimoto, H., Shintani, N., Baba, A., Shimizu, S., Yukioka, F., Kumamoto, N., Yamaguchi, A., Tohyama, M., and Katayama, T. (2007). A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol. Psychiatry 12, 398-407.
25. Hepler, D. J., Wenk, G. L., Cribbs, B. L., Olton, D. S., and Coyle, J. T. (1985). Memory impairments following basal forebrain lesions. Brain Res. 346, 8-14.
26. Holmes, A., Parmigiani, S., Ferrari, P. F., Palanza, P., and Rodgers, R. J. (2000). Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol. Behav. 71, 509-516.
27. Ishiguro, H., Ohtsuki, T., Okubo, Y., Kurumaji, A., and Arinami, T. (2001). Association analysis of the pituitary adenyl cyclase activating peptide gene (PACAP) on chromosome 18p11 with schizophrenia and bipolar disorders. J. Neural Transm. 108, 849-854.
28. Ishihama, T., Ago, Y., Shintani, N., Hashimoto, H., Baba, A., Takuma, K., and Matsuda, T. (2010). Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Behav. Brain Res. 209, 274-280.
29. Koga, M., Ishiguro, H., Horiuchi, Y., Inada, T., Ujike, H., Itokawa, M., Otowa, T., Watanabe, Y., Someya, T., and Arinami, T. (2010). Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia. Psychiatr. Genet. 20, 123-125.
30. Komada, M., Takao, K., and Miyakawa, T. (2008). Elevated plus maze for mice. J. Vis. Exp. 22, e1088.
31. Lohoff, F. W., Bloch, P. J., Weller, A. E., Ferraro, T. N., and Berrettini, W. H. (2008). Association analysis of the pituitary adenylate cyclase-activating polypeptide (PACAP/ADCYAP1) gene in bipolar disorder. Psychiatr. Genet. 18, 53-58.
32. Mastropaolo, J., Nadi, N. S., Ostrowski, N. L., and Crawley, J. N. (1988). Galanin antagonizes acetyl-choline on a memory task in basal forebrain-lesioned rats. Proc. Natl. Acad. Sci. U.S.A. 85, 9841-9845.
33. Matsuo, N., Takao, K., Nakanishi, K., Yamasaki, N., Tanda, K., and Miyakawa, T. (2010). Behavioral profiles of three C57BL/6 substrains. Front. Behav. Neurosci. 4:29. doi: 10.3389/fnbeh.2010.00029
34. McInnes, L. A., Service, S. K., Reus, V. I., Barnes, G., Charlat, O., Jawahar, S., Lewitzky, S., Yang, Q., Duong, Q., Spesny, M., Araya, C., Araya, X., Gallegos, A., Meza, L., Molina, J., Ramirez, R., Mendez, R., Silva, S., Fournier, E., Batki, S. L., Mathews, C. A., Neylan, T., Glatt, C. E., Escamilla, M. A., Luo, D., Gajiwala, P., Song, T., Crook, S., Nguyen, J. B., Roche, E., Meyer, J. M., Leon, P., Sandkuijl, L. A., Freimer, N. B., and Chen, H. (2001). Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population. Proc. Natl. Acad. Sci. U.S.A. 98, 11485-11490.
35. Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., and Tonegawa, S. (2003). Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 100, 8987-8992.
36. Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., and Crawley, J. N. (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3, 287-302.
37. Nicot, A., Otto, T., Brabet, P., and Dicicco-Bloom, E. M. (2004). Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. J. Neurosci. 24, 8786-8795.
38. Otto, C., Kovalchuk, Y., Wolfer, D. P., Gass, P., Martin, M., Zuschratter, W., Gröne, H. J., Kellendonk, C., Tronche, F., Maldonado, R., Lipp, H. P., Konnerth, A., and Schütz, G. (2001a). Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activationg polypeptide type I receotor-deficient mice. J. Neurosci. 21, 5520-5527.
39. Otto, C., Martin, M., Wolfer, D. P., Lipp, H. P., Maldonado, R., and Schütz, G. (2001b). Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res. Mol. Brain Res. 92, 78-84.
40. Powell, C. M., and Miyakawa, T. (2006). Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol. Psychiatry 59, 1198-1207.
41. Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., Ramirez, M., Engel, A., Hammack, S. E., Toufexis, D., Braas, K. M., Binder, E. B., and May, V. (2011). Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470, 492-497.
42. Rogner, U. C., and Avner, P. (2003). Congenic mice: cutting tools for complex immune disorders. Nat. Rev. Immunol. 3, 243-252.
43. Sauvage, M., Barabet, P., Holsboer, F., Bockaert, J., and Steckler, T. (2000). Mild deficit in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks. Brain Res. Mol. Brain Res. 84, 79-89.
44. Shintani, N., Tomimoto, S., Hashimoto, H., Kawaguchi, C., and Baba, A. (2003). Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci. 74, 337-343.
45. Shoji, H., Hagihara, H., Takao, K., Hattori, S., and Miyakawa, T. (2012). T-maze forced alternation and left-right discrimination tasks for assessing working and reference memory in mice. J. Vis. Exp. 60, e3300.
46. Silva, A. J., Simpson, E. M., Takahashi, J. S., Lipp, H.-P., Nakanishi, S., Wehner, J. M., Giese, K. P., Tully, T., Abel, T., Chapman, P. F., Fox, K., Grant, S., Itohara, S., Lathe, R., Mayford, M., and McNamara, J. O. (1997). Mutant mice and neuro-science: recommendations concerning genetic background. Neuron 19, 755-759.
47. Stroth, N., Holighaus, Y., Ait-Ali, D., and Eiden, L. E. (2011). PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann. N.Y. Acad. Sci. 1220, 49-59.
48. Takao, K., and Miyakawa, T. (2006a). Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice. Ann. N.Y. Acad. Sci. 1086, 144-159.
49. Takao, K., and Miyakawa, T. (2006b). Light/dark transition test for mice. J. Vis. Exp. 1, e104.
50. Takao, K., Toyama, K., Nakanishi, K., Hattori, S., Takamura, H., Takeda, M., Miyakawa, T., and Hashimoto, R. (2008). Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 1, 11.
51. Takao, K., Yamasaki, N., and Miyakawa, T. (2007). Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders. Neurosci. Res. 58, 124-132.
52. Tanaka, K., Shintani, N., Hashimoto, H., Kawagishi, N., Ago, Y., Matsuda, T., Hashimoto, R., Kunugi, H., Yamamoto, A., Kawaguchi, C., Shimada, T., and Baba, A. (2006). Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J. Neurosci. 26, 5091-5097.
53. Tanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., and Miyakawa, T. (2009). Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice. Mol. Brain 2, 19.
54. Tsai, G., and Coyle, J. T. (2002). Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42, 165-179.
55. Turnbull, G., and Bebbington, P. (2001). Anxiety and the schizophrenic process: clinical and epidemiological evidence. Soc. Psychiatry Psychiatr. Epidemiol. 36, 235-243.
56. Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H. H., Peoples, A., Makarov, V., Yoon, S., Bhandari, A., Corominas, R., Iakoucheva, L. M., Krastoshevsky, O., Krause, V., Larach-Walters, V., Welsh, D. K., Craig, D., Kelsoe, J. R., Gershon, E. S., Leal, S. M., Dell Aquila, M., Morris, D. W., Gill, M., Corvin, A., Insel, P. A., McClellan, J., King, M. C., Karayiorgou, M., Levy, D. L., DeLisi, L. E., and Sebat, J. (2011). Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizopherenia. Nature 471, 499-503.
57. Vaudry, D., Gonzalez, B. J., Basille, M., Yon, L., Fournier, A., and Vaudry, H. (2000). Pituitary adeny-late cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52, 269-324.
58. Yamasaki, N., Maekawa, M., Kobayashi, K., Kajii, Y., Maeda, J., Soma, M., Takao, K., Tanda, K., Ohira, K., Toyama, K., Kanzaki, K., Fukunaga, K., Sudo, Y., Ichinose, H., Ikeda, M., Iwata, N., Ozaki, N., Suzuki, H., Higuchi, M., Suhara, T., Yuasa, S., and Miyakawa, T. (2008). Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain 1, 6.